✦ LIBER ✦

Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experience

✍ Scribed by A. García-noblejas; C. Martínez Chamorro; B. Navarro Matilla; C. Da Silva Rodriguez; T. J. González-lopez; R. Oña Navarrete; M. J. Ramírez Sánchez; P. Martínez Barranco; J. J. Sánchez Blanco; C. Nicolás; R. Pérez; B. Sánchez González; A. M. Ruedas López; E. Domingo-domenech; C. Panizo; S. Macia; E. Fernández-fonseca; J. Cannata-ortiz; R. Arranz

Book ID: 123609728
Publisher: Springer
Year: 2014
Tongue: English
Weight: 344 KB
Volume: 93
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-014-2077-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relevance of monitoring metabolic reduct

Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine: a multicenter study

✍ Ukihide Tateishi; Mitsuaki Tatsumi; Takashi Terauchi; Kenichi Ishizawa; Michinor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

Temsirolimus and rituximab in patients w

Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study

✍ Stephen M Ansell; Hui Tang; Paul J Kurtin; Patricia A Koenig; David J Inwards; K 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 162 KB

Clinical experience of bendamustine in r

Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients

✍ Ghesquières, Hervé; Stamatoullas, Aspasia; Casasnovas, Olivier; Morschhauser, Fr 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 283 KB

Bortezomib, Bendamustine, and Rituximab

Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study

✍ Fowler, N.; Kahl, B. S.; Lee, P.; Matous, J. V.; Cashen, A. F.; Jacobs, S. A.; L 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 215 KB

Nelarabine for the Treatment of Patients

Nelarabine for the Treatment of Patients with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

✍ DeAngelo, Daniel J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Lenalidomide in combination with rituxim

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

✍ Michael Wang; Luis Fayad; Nicolaus Wagner-Bartak; Liang Zhang; Fredrick Hagemeis 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 141 KB